Financial Statements 2023

2. Notes to the IFRS Consolidated Financial Statements 2.4 Airbus Performance

13.

Research and Development Expenses

Research and development expenses increased by € +178 million to €3,257 million compared to €3,079 million in 2022 mainly due to ramp ‑ up in activities to prepare the technologies of the future.

Research and development expenses mainly reflect the development of latest generation commercial aircraft programmes, including the A321 XLR and A350 Freighter.

14.

Other Income and Other Expenses

Other income decreased by €-228 million to €243 million compared to €471 million in 2022. In 2022, it included an insurance income of €200 million linked to the launch failure of the two satellites Pléiades Neo 5 and 6 in December 2022 (see “– Note 20: Property, Plant and Equipment”).

Other expenses decreased by €-381 million to €-209 million compared to €-590 million in 2022, mainly due to the impact of €-437 million linked to the launch failure of the two satellites Pléiades Neo 5 and 6 in December 2022 (see “– Note 20: Property, Plant and Equipment”).

15.

Share of Profit from Investments Accounted for under the Equity Method and Other Income from Investments

2023

(In € million)

2022

Share of profit from investments in joint ventures

211

99

Share of profit from investments in associates

56

35

Share of profit from investments accounted for under the equity method

267

134

Other income from investments

36

58

Share of profit from investments under the equity method and other income from investments increased by €+111 million to €303 million compared to €192 million in 2022, mainly linked to higher share of result from the Company’s main joint ventures (ArianeGroup, MBDA and ATR GIE, see “Note 9.1 – Investments in Joint Ventures”).

32

Airbus

Financial Statements 2023